98%
921
2 minutes
20
Methamphetamine (METH) use disorder (MUD) is a psychiatric disease that imposes substantial health burdens throughout the world. Significant sex-specific differences in misuse and relapse rates exist among human METH users and in preclinical models of MUD. We have been using a METH self-administration (SA) model to identify molecular substrates of sex-related behavioral manifestations. Rats were trained to self-administer METH (0.1 mg/kg/injection, i.v.) over 20 days. Hippocampus (HIP), prefrontal cortex (PFC), nucleus accumbens (NAc), and dorsal striatum (dSTR) were dissected and used to measure mRNA expression of HDACs because of their potential involvement in MUD. Compared to females, males self-administered more METH. Quantitative PCR revealed that control male rats had higher basal Hdac4 mRNA levels in their HIP and Hdac10 in the PFC in comparison to female controls. In contrast, female controls had higher basal levels of Hdac1, Hdac2, Hdac5, Hdac6, Hdac7, Hdac8, Sirt1, and Sirt2 mRNAs in the PFC. In addition, female METH takers showed decreased mRNA levels of Hdac1, Hdac2, Hdac3, Hdac4, Hdac5, Hdac6, Hdac7, Hdac8 and Hdac11 in their PFC when compared to female controls. Male METH rats had increased Hdac1, Hdac2, Hdac6, Sirt1, and Sirt2 mRNA levels in their PFC, but decreased Hdac4, Sirt4 and Sirt5 mRNA levels in HIP when compared to male controls. These results provide further evidence for sexual dimorphic responses to METH after a long withdrawal interval. These observations support the notion that sex-specific therapeutic approaches using epigenetic agents may be necessary against METH use disorder.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12309524 | PMC |
http://dx.doi.org/10.1007/s12035-025-04869-7 | DOI Listing |
FASEB J
September 2025
Department of Hematology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.
Epilepsy is a common chronic nervous system disease that threatens human health. However, the role of FOXC1 and its relations with pyroptosis have not been fully studied in epilepsy. Sprague-Dawley rats were obtained for constructing temporal lobe epilepsy (TLE) models.
View Article and Find Full Text PDFCleft Palate Craniofac J
September 2025
School and Hospital of Stomatology, Zunyi Medical University, Zunyi, China.
ObjectiveTo investigate the effects of zinc concentration on palatal development in fetal mice and its association with the aryl hydrocarbon receptor (AhR) signaling pathway.MethodsPregnant C57BL/6J mice were fed diets with varying zinc concentrations and randomly divided into a zinc-rich (ZR) group, a normal-zinc (NZ) group, and a zinc-deficient (ZD) group. Embryonic development was observed, and the expression levels of AhR signaling pathway-related factors were examined.
View Article and Find Full Text PDFmBio
September 2025
Department of Microbiology & Immunology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Fatty acid-binding protein 4 (FABP4) is a cytosolic lipid chaperone predominantly expressed in adipocytes. It has been shown that targets adipose tissues and resides in adipocytes. However, how manipulates adipocytes to redirect nutrients for its benefit remains unknown.
View Article and Find Full Text PDFFront Mol Biosci
August 2025
Department of Neurosurgery, Jiangnan University Medical Center, Wuxi, Jiangsu, China.
Introduction: Sulforaphane (SFN) is recognized for its anti-inflammatory properties; however, the underlying molecular mechanisms remain unclear. In this study, we explored the effect of SFN on subarachnoid hemorrhage (SAH) and the potential mechanisms.
Methods: Sprague-Dawley (SD) rats were divided into three groups (n = 12): Sham + vehicle group (Sham + V), SAH + vehicle group (SAH + V), and SAH + SFN group (SAH + S).
Front Genet
August 2025
Laboratory of Cellular Biochemistry and Molecular Biology, CRIBENS, Catholic University of the Sacred Heart, Milan, Italy.
Neutral Lipid Storage Disease with Myopathy (NLSDM) is a rare lipid metabolism disorder caused by impaired Adipose Triglyceride Lipase (ATGL) activity, leading to neutral lipid accumulation in various tissues. It typically manifests with progressive skeletal myopathy, with an onset of around 35 years. In addition, some patients develop cardiomyopathy and liver dysfunction.
View Article and Find Full Text PDF